Rockefeller Capital Management
DFTX

Rockefeller Capital Management’s Definium Therapeutics DFTX Stock Holding History

Rockefeller Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Buy
55,206
+54,855
+15,628% +$931K ﹤0.01% 1591
2025
Q4 		$4.7K Hold
351
– – ﹤0.01% 4089
2025
Q3 		$4.14K Buy
+351
New +$3.27K ﹤0.01% 3927
2023
Q1 		– Sell
-148
Closed – – 3149
2022
Q4 		$0 Hold
148
– – ﹤0.01% 4075
2022
Q3 		$0 Sell
148
-1
-0.7% -$10 ﹤0.01% 4192
2022
Q2 		$1K Hold
149
– – ﹤0.01% 3985
2022
Q1 		$2K Hold
149
– – ﹤0.01% 3623
2021
Q4 		$3K Hold
149
– – ﹤0.01% 3445
2021
Q3 		$5K Sell
149
-10
-6% -$432 ﹤0.01% 3177
2021
Q2 		$8K Buy
+159
New +$8.35K ﹤0.01% 2877

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rockefeller Capital Management's DFTX Position: Q1 2026 in Review

Rockefeller Capital Management increased its Definium Therapeutics (DFTX) stake by 15,628% in Q1 2026, buying an estimated $931K and bringing the position to 55,206 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

Rockefeller Capital Management first reported a position in DFTX in Q2 2021 and has held it in 10 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Rockefeller Capital Management held 55,206 shares of Definium Therapeutics worth $1.04M as of Q1 2026.
  • Rockefeller Capital Management bought 54,855 Definium Therapeutics shares in Q1 2026, an estimated $931K.
  • Definium Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1591 holding.
  • Rockefeller Capital Management first reported a position in Definium Therapeutics in Q2 2021 and has held it in 10 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.